July 24, 2024 MedPage explains how FDA’s new meetings are called expert panels but their “experts” seem to have one thing in common: they agree on one side of controversial issues, such as the safety of hormone therapy despite reported cancer risks, the risks of talc for cancer, and the risks of SSRIs (depression drugs). We tell MedPage that the meeting rooms are small and filled primarily with supporters and no public questions or comments are allowed. The meetings are not announced to the general public and usually only a few days in advance. We explain all the reasons why this is the opposite of the transparency we were promised by HHS.
Read More »Medical Care for Adults
The National Center for Health Research reviews important new research as soon as it is published. We cut through the hype regarding various medical treatments to let you know what is proven and what is unknown about the risks and benefits of various treatment options. We do not accept funding from the companies that make medical products, so you can trust that our information is based on science, and not biased by financial ties to the treatments we’re evaluating.
To find the information you need, please use our search box to search for exactly what you are looking for or browse through our various topics on the right. →
Some of these articles were written this year and others were not, however, if they are on our website it means the information is up-to-date. We always scrutinize new research and call the researchers to learn even more. Then we translate it into plain language that everyone can understand.
If you’re looking for more detailed information about cancer, please go to our Cancer Prevention and Treatment website.
If you don’t see what you are looking for on any health topic, please contact us and we will try to get the information you need within a few days.
High Blood Pressure (Hypertension): What Is It and How Do You Control It?
High blood pressure is the most commonly diagnosed health problem in this country; it can lead to heart attack, stroke, kidney failure, and death if not detected early and appropriately treated.
Read More »NCHR Testimony regarding Front-of-Package Nutrition Information Labeling
July 15, 2025: NCHR submitted written comments to the U.S. Food and Drug Administration in support of the proposed rule on front-of-package nutrition labeling, recommending stronger, clearer labeling requirements, especially for young children. They suggested additional testing to ensure consumers understand and benefit from the labels, including those with limited literacy or English proficiency.
Read More »FDA Panel to Revisit Menopausal Hormone Therapy
Politico; July 15, 2025: This article describes the FDA panel on the risks and benefits of hormone therapy for menopause: breast cancer, heart disease,stroke, dementia. Zuckerman points out that the panel is one-sided, ignoring data on risks and not allowing public comments from patients or experts to ask questions or describe studies indicating cancer and other serious risks.
Read More »NCHR Comments on AHRQ’s Mindfulness-Based Interventions for Mental Health and Wellbeing in Children and Adolescents
The following written comment was submitted by the Health Policy Director, Dr. Amanda Berhaupt at The National Center for Health Research’ (NCHR) to the Agency of Health Research and Quality (AHRQ). AHRQ requested comments on the protocol for the Mindfulness-Based Interventions (MBI) for Mental Health and Wellbeing in Children and Adolescents: A Systematic Review by […]
Read More »